- Sotorasib - Wikipedia
In January 2025, the FDA approved sotorasib, in combination with panitumumab, for the treatment of adults with KRAS G12C-mutated metastatic colorectal cancer, as determined by an FDA-approved test, who have received prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy
- Sotorasib: Uses, Dosage, Side Effects, Warnings - Drugs. com
Sotorasib is an oral targeted cancer treatment used to treat KRAS G12C-mutated non-small cell lung cancer (NSCLC) or colorectal cancer (CRC) in adults It is a tablet that is taken once a day The brand name is Lumakras Includes sotorasib's mechanism, side effects, and interactions
- Sotorasib (oral route) - Side effects dosage - Mayo Clinic
Sotorasib is used to treat metastatic (cancer that has already spread) or locally advanced (cannot be removed by surgery) non-small cell lung cancer (NSCLC) in patients who have received at least one previous treatment and whose tumors have an abnormal KRAS G12C gene
- Sotorasib for Lung Cancers with KRAS p. G12C Mutation
We conducted a multicenter, single-group, open-label, phase 2 trial to evaluate the efficacy and safety of sotorasib as monotherapy in patients with locally advanced or metastatic KRAS
- Sotorasib: MedlinePlus Drug Information
Sotorasib is used to treat certain types of lung cancer (non-small cell lung cancer; NSCLC) and cancer of the colon (large intestine) or rectum Sotorasib is in a class of medications called KRAS inhibitors
- LUMAKRAS® (sotorasib) Dosing | Oral KRAS G12C Inhibitor
Monitor patients for new or worsening pulmonary symptoms indicative of ILD pneumonitis (e g , dyspnea, cough, fever) Immediately withhold LUMAKRAS ® in patients with suspected ILD pneumonitis and permanently discontinue LUMAKRAS ® if no other potential causes of ILD pneumonitis are identified
- Lumakras (sotorasib) - Uses, Side Effects, and More - WebMD
Lumakras (sotorasib) is commonly used to treat certain types of non-small-cell lung cancer (NSCLC) and colorectal cancer Lumakras may also be used for other conditions as determined by your
- Sotorasib - NCI - National Cancer Institute
This page contains brief information about sotorasib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials
|